Skip to main content
TMO logo
TMO
(NYSE)
Thermo Fisher Scientific Inc.
$491.46-- (--)
Loading... - Market loading

Thermo Fisher Scientific (TMO) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Thermo Fisher Scientific Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Thermo Fisher Scientific Inc. (TMO) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents9.854.018.088.524.4810.332.402.101.34
Short-Term Investments0.251.560.000.000.000.000.000.000.00
Cash & Short-Term Investments10.115.578.088.524.4810.332.402.101.34
Accounts Receivable8.908.199.668.128.956.474.954.603.88
Inventory5.434.985.095.635.054.033.373.012.97
Other Current Assets2.611.961.761.641.641.131.170.921.24
Total Current Assets28.7122.1424.5925.2320.1121.9611.8910.639.42
Non-Current Assets
Property, Plant & Equipment (Net)10.579.3111.009.289.866.695.454.174.05
Long-Term Investments0.540.440.530.150.070.070.040.050.03
Goodwill49.3645.8544.0241.2041.9226.0425.7125.3525.29
Intangible Assets15.8415.5316.6717.4420.1512.6914.0114.9816.68
Other Non-Current Assets5.874.491.914.013.001.571.281.061.19
Total Non-Current Assets81.6475.1874.1471.9375.0147.1046.4945.6147.25
Total Assets110.3497.3298.7397.1595.1269.0558.3856.2356.67
Current Liabilities
Accounts Payable3.623.082.873.382.872.181.921.621.43
Short-Term Debt3.532.213.615.582.802.810.841.272.14
Current Portion of Long-Term Debt3.532.203.615.270.000.000.000.000.00
Accrued Liabilities5.325.194.525.455.090.000.000.000.00
Deferred Revenue2.712.852.692.602.661.270.920.810.72
Other Current Liabilities5.050.050.060.065.114.052.522.452.33
Total Current Liabilities15.1913.3314.0117.0113.4410.306.206.157.05
Non-Current Liabilities
Long-Term Debt35.8529.0631.4128.9133.5419.7317.6517.7318.88
Deferred Tax Liabilities1.491.271.922.853.841.792.192.272.77
Other Non-Current Liabilities4.273.991.234.242.101.942.082.162.57
Total Non-Current Liabilities41.6234.3237.8736.0040.7124.2322.5122.5024.21
Total Liabilities56.8147.6551.8853.0154.1534.5428.7128.6531.26
Stockholders' Equity
Common Stock0.450.440.440.440.440.440.430.430.43
Retained Earnings59.1653.1047.3641.9135.4328.1222.0918.7015.91
Accumulated Other Comprehensive Income-2.45-2.70-3.22-3.10-2.33-2.81-2.68-2.50-2.00
Treasury Stock22.3119.2315.1312.028.920.000.000.000.00
Additional Paid-in Capital18.5617.9617.2916.747.258.769.8310.9611.07
Minority Interest0.130.090.110.170.180.010.000.000.00
Shares Outstanding0.380.380.390.390.390.000.000.000.00
Total Stockholders' Equity53.4149.5946.8443.9840.7934.5129.6827.5925.41
Total Liabilities & Equity110.3497.3298.7397.1595.1269.0558.3856.2356.67

Frequently Asked Questions About Thermo Fisher Scientific Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is TMO's debt level?

Review Thermo Fisher Scientific's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.